Brown P; RELISH Consortium （Tanino Y et al.）, Zhou Y. Large expert-curated database for benchmarking document similarity in biomedical literature search. Database: The Journal of Biological Databases and Curation. 201910; 2019:baz085.
Nakano H, Inoue S, Shibata Y, Abe K, Murano H, Yang S, Machida H, Sato K, Sato C, Nemoto T, Nishiwaki M, Kimura T, Yamauchi K, Sato M, Igarashi A, Tokairin Y, Watanabe M. E-selectin as a prognostic factor of patients hospitalized due to acute inflammatory respiratory diseases: A single institutional study. EXCLI Journal. 201911; 18:1062-1070.
Tanino Y, Wang X, Nikaido T, Misa K, Sato Y, Togawa R, Kawamata T, Kikuchi M, Frevert C, Tanino M, Kojima T, Shibata Y. Syndecan-4 inhibits the development of pulmonary fibrosis by attenuating TGF-β signaling. International Journal of Molecular Sciences. 201910; 20（20）:4989.
Gono T, Tanino Y, Nishikawa A, Kawamata T, Hirai K, Okazaki Y, Shibata Y, Kuwana M. Two cases with autoantibodies to small ubiquitin-like modifier activating enzyme: A potential unique subset of dermatomyositis-associated interstitial lung disease. International Journal of Rheumatic Diseases. 201908; －128－ 22（8）:1582-1586.
Paz-Ares L, Dvorkin M, Chen Y, Reinmuth N, Hotta K, Trukhin D, Statsenko G, Hochmair MJ, Özgüroğlu M, Ji JH, Voitko O, Poltoratskiy A, Ponce S, Verderame F, Havel L, Bondarenko I, Kazarnowicz A, Losonczy G, Conev NV, Armstrong J, Byrne N, Shire N, Jiang H, Goldman JW; CASPIAN investigators （Kanazawa K et al.）. Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer （CASPIAN）: a randomised, controlled, open-label, phase 3 trial. Lancet. 201911; 394（10212）:1929-1939.
Suzuki Y, Kanazawa K, Kanai R, Tomita H, Saito M, Watanabe N, Morimoto J, Umeda T, Kawamata T, Rikimaru M, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Minemura H, Nikaido T, Fukuhara A, Sato S, Saito J, Tanino Y, Mori K, Shibata Y. A case of primary lung squamous cell carcinoma mimicking malignant mesothelioma producing granulocyte colony stimulating factor with chemotherapy （cisplatin and gemcitabine）associated thrombotic thrombocytopenic purpura （TTP）; An autopsy case report. Lung Cancer. 201910; 136:105-108.
Asahina H, Oizumi S, Takamura K, Harada T, Harada M, Yokouchi H, Kanazawa K, Fujita Y, Kojima T, Sugaya F, Tanaka H, Honda R, Kikuchi E, Ikari T, Ogi T, Shimizu K, Suzuki M, Konno S, Dosaka-Akita H, Isobe H, Nishimura M; Hokkaido Lung Cancer Clinical Study Group. A prospective phase II study of carboplatin and nab-paclitaxel in patients with advanced non-small cell lung cancer and concomitant interstitial lung disease （HOT1302）. Lung Cancer. 201912; 138:65-71.
Furuta M, Sakakibara-Konishi J, Kikuchi H, Yokouchi H, Nishihara H, Minemura H, Harada M, Yamazaki S, Akie K, Fujita Y, Takamura K, Kojima T, Harada T, Minami Y, Watanabe N, Oizumi S, Suzuki H, Nishimura M, Dosaka-Akita H, Isobe H; Hokkaido Lung Cancer Clinical Study Group. Analysis of DLL3 and ASCL1 in Surgically Resected Small Cell Lung Cancer （HOT1702）. Oncologist. 201911; 24（11）:e1172-e1179.
Minegishi Y, Inoue S, Sato K, Abe K, Murano H, Furuyama K, Yang S, Machida H, Nakano H, Sato M, Nemoto T, Sato C, Nishiwaki M, Kimura T, Yamauchi K, Igarashi A, Tokairin Y, Shibata Y, Watanabe M. Smaller erector spinae muscle size is associated with inability to recover activities of daily living after pneumonia treatment. Respiratory investigation. 201903; 57（2）:191-197.
Shibata Y. Mysterious link between the restrictive ventilatory impairment in spirometry and cardiovascular disease. Respiratory investigation. 201905; 57（3）:199-200.
Shibata Y, Inoue S, Watanabe M. Impact of reduced pulmonary function in the Japanese general population: Lessons from the Yamagata-Takahata study. Respiratory investigation. 201905; 57（3）:220-226.
Nikaido T, Tanino Y, Sato Y, Togawa R, Wang X, Shibata Y. Syndecans in Pulmonary Diseases. In: Berhardt LV editor. Advances in Medicine and Biology （Series Vol.138）. New York, USA: Nova Science Publishers; 201903. p.171-193.
Togawa R, Tanino Y, Nikaido T, Sato Y, kawamata T, Saito M, Watanabe N, Umeda T, Rikimaru M, Suzuki Y, Uematsu M, Minemura H, Fukuhara A, Sato S, Saito J, Kanazawa K, Shibata Y. Are the Autoantibodies Associated with The Distinctive Clinical Characteristics in Interstitial Pneumonia Patients with Systemic Sclerosis? 2019 ATS International Conference; 20190519; Dallas, USA.
Enomoto N, Homma S, Inase N, Takizawa H, Inoue Y, Ishii H, Taguchi Y, Izumi S, Yamano Y, Tanino Y, Nishioka Y, Toyoshima M, Yokomura K, Imokawa S, Koshimizu N, Suda T. Prognostic analysis of idiopathic interstitial pneumonias with rheumatologic features: A prospective multicenter cohort study (PAIR cohort study). 2019 ATS International Conference; 20190520; Dallas, USA.
Nikaido T, Tanino Y, Sato Y, Togawa R, Kawamata T, Saito M, Watanabe N, Umeda T, Rikimaru M, Suzuki Y, Uematsu M, Minemura H, Fukuhara A, Sato S, Saito J, Kanazawa K, Shibata Y. Baseline Serum Lactate Dehydrogenase and %VC may Predict the Short Time Decline of FVC in Patients with Idiopathic Pulmonary Fibrosis. 2019 ATS International Conference; 20190520; Dallas, USA.
Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Saito M, Watanabe N, Umeda T, Rikimaru M, Suzuki Y, Uematsu M, Minemura H, Fukuhara A, Sato S, Saito J, Kanazawa K, Shibata Y. Clinical Significance of Desaturation during a 6-minute Walk Test in Patients with Idiopathic Interstitial Pneumonia without Hypoxemia at Rest. 2019 ATS International Conference; 20190520; Dallas, USA.
Suzuki T, Wang X, Nikaido T, Tanino Y, Saitou M, Munakata M, Shibata Y, Niitsuma K. PAR-2 antagonist inhibits BLM-induced lung fibrosis. ERS International Conference; 20190929; Madrid, Spain.
Suzuki Y, Saito J, Rikimaru M, Uematsu M, Fukuhara A, Sato S, Kawamata T, Togawa R, Nikaido T, Fukuhara N, Tanino Y, Shibata Y. Clinical application of sputum hydrogen sulfide and YKL-40 in Asthma, ACO and COPD. ERS International Conference; 20190929; Madrid, Spain.
Uematsu M, Saito J, Sato S, Fukuhara A, Suzuki Y, Rikimaru M, Tomita H, Watanabe N, Umeda T, Kawamata T, Togawa Y, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y. Usefulness of fraction of exhaled nitric oxide and asthma management questionnaires in predicting a future risk of asthma exacerbation. Congress of European Respiratory Society; 20190930; Madrid, Spain.
Saito J, Fukuhara A, Birring SS, Sato S, Uematsu M, Suzuki Y, Rikimaru M, Watanabe N, Saito M, Kawamata T, Umeda T, Togawa R, Sato Y, Hirai K, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Munakata M, Shibata Y. Clinical characteristics of cough frequency patterns in patients with and without asthma. Annual Congress of European Respiratory Society; 20191001; Madrid, Spain.
Nikaido T, Tanino Y, Wang X, Sato Y, Togawa R, Kawamata T, Kikuchi M, Frevert CW, Tanino M, Kojima T, Shibata Y. Syndecan-4 inhibits the development of pulmonary fibrosis by attenuating TGF-β signaling. 11th International Conference on Proteoglycan; 20191002; Kanazawa.
Kawamata T, Tanino Y, Nikaido T, Sato Y, Togawa R, Tomita H, Watanabe N, Umeda T, Rikimaru M, Suzuki Y, Uematsu M, Minemura H, Fukuhara A, Saito J, Kanazawa K, Shibata Y. Clinical Characteristics of Idiopathic Interstitial Pneumonia with Anti-ARS Antibody. WASOG/JSSOG 2019; 20191011; Yokohama.
Gono T, Masui K, Nishina N, Sato S, Kuwana M; JAMI investigators. Predictive factors for mortality in antimelanomaassociated gene 5 antibody-associated interstitial lung disease. ACR/ARP Annual Meeting; 20191112; Atlanta, USA.
